Ms. Bracken joined Domain in 2006. Present board observer positions include Acureon Pharmaceuticals, Asmacure Inc., Immune Control, Nuon Therapeutics, OmniSonics, and VentiRx. Prior to joining Domain, she was a consultant with Easton Associates (formerly The Wilkerson Group), a management consultancy dedicated to the medical industry. While with Easton Associates, she worked for a broad spectrum of clients ranging from start-ups to global pharmaceutical and device companies. Ms. Bracken advised clients on general corporate strategy, marketing and sales tactics, product life-cycle planning, clinical development plans, M&A opportunities, and business development activities. She earned a bachelor’s degree in molecular and cellular biology from Harvard University, and conducted research on embryonic stem cells as a model for Parkinson’s Disease at Harvard.